Renub Research

North America Cervical Cancer Screening Market is projected to US$ 100 Million by 2024

Press release   •   Apr 30, 2019 01:05 EDT

Access full Research:

Get Free Customization in This Report

Cervical cancer is the fourth most common cancer prevailing in women and the seventh in terms of overall cancer incidences. North America Cervical Cancer Screening Market is projected to reach US$ 100 Million by the year 2024. Cervical cancer affects the lower part of the uterus (womb). Cervical cancer generally occurs in women over 30 years. It is mostly caused by the Human papillomavirus (HPV) virus.

Increasing cervical cancer prevalence rate is one of the key factors that drive the cervical cancer screening market. Rapidly increasing female population, growing incidence of HPV infections and increasing awareness about cervical cancer screening programs is also expected to drive the cervical cancer screening market in the near future.

Request a free sample copy of the report:

Renub Research report titled “USA & Canada Cervical Cancer Diagnostic Market, Patients by Test Type (Pap Smear, HPV DNA), in North America” provides a complete analysis of North America Cervical Cancer Screening Market. The report provides a complete analysis of North America Cervical Cancer Test Market, Screened Population & Mortality.

By Test Types – Pap smear Screening Tests is gaining popularity in North America

The report studies the market and population of the following cervical cancer screening tests: Pap smear Tests and HPV DNA Tests. Pap smear and HPV DNA tests are more popular with the developed countries such as United States.

By Country – United State has bright future in Cervical Cancer Screening Market in near future

The report studies the market/screened population of two big North America’s country (United State and Canada) which provides a complete country-wise analysis of North America Cervical Cancer Screening Market, Population and Mortality.

Client can purchase this report in sections through Purchase by Chapter Tab given above

Cervical Cancer Diagnostic Market & Population

  • Pap Smear Tests Market
    • HPV DNA Tests Market
  • Cervical Cancer Mortality Population
  • United State
    • Canada
  • Contact Us


    Phone: +1-678-302-0700


    Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.

    Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets.